IL116935A0 - Venlafaxine for the treatment of hypothalmic amenorrhea - Google Patents

Venlafaxine for the treatment of hypothalmic amenorrhea

Info

Publication number
IL116935A0
IL116935A0 IL11693596A IL11693596A IL116935A0 IL 116935 A0 IL116935 A0 IL 116935A0 IL 11693596 A IL11693596 A IL 11693596A IL 11693596 A IL11693596 A IL 11693596A IL 116935 A0 IL116935 A0 IL 116935A0
Authority
IL
Israel
Prior art keywords
hypothalmic
venlafaxine
amenorrhea
treatment
hypothalmic amenorrhea
Prior art date
Application number
IL11693596A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23502899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL116935(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL116935A0 publication Critical patent/IL116935A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11693596A 1995-01-30 1996-01-29 Venlafaxine for the treatment of hypothalmic amenorrhea IL116935A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/380,903 US5506270A (en) 1995-01-30 1995-01-30 Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women

Publications (1)

Publication Number Publication Date
IL116935A0 true IL116935A0 (en) 1996-05-14

Family

ID=23502899

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11693596A IL116935A0 (en) 1995-01-30 1996-01-29 Venlafaxine for the treatment of hypothalmic amenorrhea

Country Status (17)

Country Link
US (1) US5506270A (fr)
EP (1) EP0723779A1 (fr)
JP (1) JPH08231387A (fr)
KR (1) KR960028906A (fr)
CN (1) CN1137894A (fr)
AR (1) AR001074A1 (fr)
AU (1) AU703529B2 (fr)
CA (1) CA2167999A1 (fr)
CZ (1) CZ22996A3 (fr)
FI (1) FI956339A (fr)
HU (1) HUT75095A (fr)
IL (1) IL116935A0 (fr)
NO (1) NO955356L (fr)
NZ (1) NZ280744A (fr)
PE (1) PE13197A1 (fr)
SK (1) SK11596A3 (fr)
ZA (1) ZA9511038B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
US20030215507A1 (en) * 1996-03-25 2003-11-20 Wyeth Extended release formulation
US20060067999A1 (en) * 1996-03-25 2006-03-30 Wyeth Extended release formulation
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
EP1905757A1 (fr) * 1999-04-06 2008-04-02 Sepracor Inc. Dérivés de venlafaxine et leurs procédés de préparation et d'utilisation
US20020022662A1 (en) * 1999-06-15 2002-02-21 American Home Products Corporation Enantiomers of O-desmethyl venlafaxine
US20020035158A1 (en) * 1999-06-15 2002-03-21 American Home Products Corporation Enantiomers of N-desmethyl venlafaxine
US6348494B1 (en) 2000-11-21 2002-02-19 American Home Products Corporation Ethers of o-desmethyl venlafaxine
US7291646B2 (en) * 1999-11-24 2007-11-06 Wyeth Ethers of O-desmethyl venlafaxine
US6572890B2 (en) * 2000-01-13 2003-06-03 Osmotica Corp. Osmotic device containing venlafaxine and an anti-psychotic agent
FR2807753B1 (fr) * 2000-04-13 2002-06-07 Adir Nouveaux derives d'heterocycloalkylbenzocyclobutane et d'heteroarylbenzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6673838B2 (en) * 2001-02-12 2004-01-06 Wyeth Succinate salt of O-desmethyl-venlafaxine
EP1451145A1 (fr) * 2001-12-05 2004-09-01 Wyeth Nouvelle forme cristalline polymorphe d'hydrochlorure de venlafaxine et methodes de preparation de ladite forme
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
US20030190351A1 (en) * 2002-03-28 2003-10-09 Synthon Bv Extended release venlafaxine formulations
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
EP1523981A1 (fr) * 2003-10-13 2005-04-20 Wyeth Préparations à libération prolongée de la venlafaxine
EP1523979A1 (fr) * 2003-10-13 2005-04-20 Wyeth Forme d'administration de libération prolongée
MX2008000249A (es) * 2005-07-06 2008-03-18 Sepracor Inc Combinaciones de eszopiclona y o-desmetilvenlafaxina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y cognitivos.
US7612210B2 (en) * 2005-12-05 2009-11-03 Wyeth Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
KR100965527B1 (ko) * 2008-05-08 2010-06-23 제일약품주식회사 신규(4-(2-(디메틸아미노)-1-(1-하이드록시사이클로헥실)에틸)페녹시)포스페이트 또는 이의 약학적으로 허용가능한 염,이의 제조방법 및 이를 유효성분으로 함유하는 중추신경계질환 예방 및 치료용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110438A (en) * 1977-03-21 1978-08-29 American Home Products Corporation Method of treating depression
US4292315A (en) * 1977-12-30 1981-09-29 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4291028A (en) * 1977-12-30 1981-09-22 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4611078A (en) * 1983-10-26 1986-09-09 American Home Products Corporation Substituted phenylacetonitriles
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
US4826844A (en) * 1987-09-30 1989-05-02 American Home Products Corporation Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence

Also Published As

Publication number Publication date
US5506270A (en) 1996-04-09
FI956339A (fi) 1996-07-31
AR001074A1 (es) 1997-09-24
AU703529B2 (en) 1999-03-25
CN1137894A (zh) 1996-12-18
HUT75095A (en) 1997-04-28
NO955356D0 (no) 1995-12-29
NZ280744A (en) 2000-11-24
AU4075295A (en) 1996-08-08
FI956339A0 (fi) 1995-12-29
CZ22996A3 (en) 1996-09-11
EP0723779A1 (fr) 1996-07-31
JPH08231387A (ja) 1996-09-10
CA2167999A1 (fr) 1996-07-31
NO955356L (no) 1996-07-31
HU9503922D0 (en) 1996-03-28
KR960028906A (ko) 1996-08-17
PE13197A1 (es) 1997-04-22
ZA9511038B (en) 1997-06-30
SK11596A3 (en) 1997-05-07

Similar Documents

Publication Publication Date Title
IL116935A0 (en) Venlafaxine for the treatment of hypothalmic amenorrhea
GB2318055B (en) Dosage form comprising oxybutynin
IL117188A0 (en) Process for the preparation of thietanones
HUP9802445A3 (en) Liposomal oligonucleotide compositions and process for inhibiting the human raf
SG55239A1 (en) Process for the preparation of dihaloazpyrimidines
AU5750796A (en) System for the treatment of insomnia
IL121437A0 (en) Process for the preparation of nootkatone
EP0761718A3 (fr) Procédé pour la préparation de poly-o-hydroxyamides et de poly-o-mercaptoamides
GB9519033D0 (en) Treatment
EP0761721A3 (fr) Procédé pour la préparation de poly-o-hydroxyamides et de poly-o-mercaptoamides
IL113057A0 (en) Compositions for the treatment of dandruff
HRP960357B1 (en) Process for the preparation of lovastatin
EP0770598A3 (fr) Procédé pour la préparation de carbazates
EP0859761A4 (fr) 4-azasteroides utilises pour le traitement d'etats hyperandrogeniques
EP0761719A3 (fr) Procédé pour la préparation de poly-o-hydroxyamides et de poly-o-mercaptoamides
IL125004A0 (en) Process for the preparation of 9,11 beta-epoxide steroids
EP0800396A4 (fr) Traitement d'etats d'hyperandrogenie
IL115090A0 (en) Process for the preparation of p-bromofluorobenzene
EP0761720A3 (fr) Procédé pour la préparation de poly-o-hydroxyamides et de poly-o-mercaptoamides
ZA9610281B (en) Process for the preparation of pesticides
EP0724842A3 (fr) Préparation pour le traitement de l'obésité
IL117968A0 (en) Process for the preparation of streptogramins
ZA968873B (en) Isomerisation of equillin
ZA965515B (en) Process for the preparation of 3-hydroxyoxetanes
IL118732A (en) Process for the preparation of arylidene-substituted alkylcycloalkanones